Home › stem cells ›

stem cells

BioDigest: Geron

Posted by ecreese on December 3, 2009 at 9:14am EST

See what strides are being made in the field of stem cell research at Geron - a Menlo Park, CA based company currently working on stem-cell based treatments for heart disease, diabetes, osteoporosis, osteoarthritis, liver disease, and cancer, as well as a treatment for spinal cord injuries.  Watch and learn how these cells work, and what their promise could hold for the future of medical treatment.

 

 

Download to listen or view the podcast.

BioBytes: What are Biotech Therapies?

Posted by ecreese on October 13, 2009 at 11:04am EDT

Join Dr. Targan as he explains biotech therapies - what they are, why they are different from traditional therapies, and how you and I are benefitting from them daily.

 

Download to listen or view the podcast.

Michael Werner on the New NIH Stem Cell Guidelines

Posted by TracyatBIO on July 9, 2009 at 9:13am EDT

BIOtech Now's Tracy Krughoff talks to Michael Werner, a partner at Holland & Knight, about the new stem cell guidelines issued by the NIH earlier this week.

Induced Pluripotent Stem Cells Revisited – Where Are We Now and Where Are We Going?

Posted by susanatbio on May 20, 2009 at 4:57pm EDT

Induced Pluripotent Stem (iPS) cells are created by re-programming a differentiated cell into a pluripotent state. Once that occurs, iPS cells demonstrate many of the properties of embryonic stem cells.

Podcast: Tricia Brooks and James Trussell Discuss Stem Cell Research and Parkinson's Cures

Posted by susanatbio on May 20, 2009 at 10:22am EDT
BIO supports all avenues of research to investigate therapies for debilitating diseases such as Parkinson's. Tricia Brooks represents BIO and James Trussell represents the Parkinson's Action Network.

Jonas Frisén of the Karolinska Institute Discusses Stem Cell Research

Posted by danmcgirt on April 4, 2009 at 5:37pm EDT

BIOtech Now's Tracy Krughoff speaks with Jonas Frisén of the Karolinska Institute in Stockholm, Sweden about his session on stem cells at the upcoming BIO International Convention.

Listen or download the podcast.

BIO leaders Joshua Boger and Jim Greenwood discuss challenges and opportunities for the biotech industry in the Obama Administration and the new Congress

Posted by danmcgirt on November 20, 2008 at 2:15pm EST

In BIOtech Now's exclusive interview with Dr. Joshua Boger (Chairman and CEO of Vertex Pharmaceuticals, Incorporated and Chairman of BIO) and James C.

This week's Top Biotech Bioethics News: Pfizer’s stem cell ventures, Eli Lilly’s DR payment disclosures, & Supreme Court Case Wyeth v. Levine's Preemption Temptation

Posted by Jennifer Miller Bioethicist on October 1, 2008 at 1:53pm EDT

Pfizer and Eli Lilly have been noteworthy with respect to their efforts to produce responsible innovations this week.  Pfizer is advancing responsible stem cell research by currently focusing on induced pluripotent stem cells (iPs) and Eli Lilly is setting a great example regarding industry disclosures and increased transparency.

  • Medical News Today reports, Pfizer, the world’s largest drug company, is getting into stem cel

Wisconsin, It's Not Just for Cheese Anymore

Posted by patentbaristas on June 18, 2008 at 9:29am EDT

Wisconsin Governor Jim Doyle held a press conference this afternoon on why Wisconsin is way more than cheese.  Announcing that the Genetics Policy Institute picked Wisconsin as the host of the 2008 World Stem Cell Summit, Gov.

Syndicate content